IPSEN BioPharmaceuticals, Inc.
- Membership Level
- Company Headquarters
- Basking Ridge, NJ
- (855) 463-5127
Ipsen Biopharmaceuticals and its research and development team are part of an innovation-driven international specialty pharmaceutical group (the Ipsen Group), with global headquarters in Paris and US headquarters in Basking Ridge, NJ (commercial/marketing), and Massachusetts (research and development). The global company markets more than 20 drugs and employs nearly 4,600 people around the world. Ipsen US focuses its resources, investments, and energy on finding new therapeutic options for endocrine, neurologic, and oncologic diseases.
Somatuline Depot: http://net.somatulinedepot.com/
Ipsen Cares: http://ipsencares.com/
Ipsen dedicated Patient Access Specialist – Click Here to Read More
Ipsen announces the FDA Approval of Somatuline Depot (lanreotide) Injection for the treatment of gastroenteropancreatic neuroendocrine tumors – Click Here To Read More
New England Journal of Medicine publishes Ipsen’s Somatuline® CLARINET® Phase III results in patients with metastatic gastroenteropancreatic neuroendocrine tumors Click Here to Read More